Mayo Clinic News Network

News Resources

Items tagged as "Dr Derek Johnson"

Bevacizumab for Glioblastoma: Mayo Clinic Radio Health Minute

In this Mayo Clinic Radio Health Minute, Dr. Derek Johnson comments on a study which looked at whether certain medication improves survival for patients with glioblastoma, an aggressive form of brain cancer. To listen, click the link below. Bevacizumab for Glioblastoma

Created by Joel Streed

Mejor supervivencia para cáncer cerebral después de autorización del bevacizumab por la FDA, descubre estudio de Mayo

ROCHESTER, Minnesota - 19 de agosto de 2013.   Un nuevo estudio poblacional descubrió que los pacientes con glioblastoma fallecidos en el año 2010, después de la autorización por parte de la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) del bevacizumab, vivieron significativamente más largo que otros pacientes [...]

Created by Soledad Andrade

Brain Cancer Survival Improved Following FDA Approval of Bevacizumab, Mayo Study Finds

ROCHESTER, Minn. — A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the [...]

Created by mayonewsreleases

Log in

version 2.8.2.2
Page loaded in 0.298 seconds